Market Cap 179.57M
Revenue (ttm) 10.68M
Net Income (ttm) -27.82M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -260.49%
Debt to Equity Ratio 0.09
Volume 10,400
Avg Vol 63,102
Day's Range N/A - N/A
Shares Out 30.05M
Stochastic %K 24%
Beta 0.49
Analysts Strong Sell
Price Target $12.31

Company Profile

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or phys...

Industry: Medical Devices
Sector: Healthcare
Phone: 647 476 1350
Fax: 647 847 3739
Address:
2400 Skymark Avenue, Unit 6, Mississauga, Canada
johntarlick
johntarlick Jul. 4 at 2:15 AM
another Canadian medtech with some parallels to $PROF (Synaptive) has just emerged from bankruptcy, with some new investment and an unknown future. Much like $PROF, they pioneered a new surgical tool with image-guidance. Like TulsaPro, the Synaptive exoscope was technically best in class. Like $PROF, Synaptive struggled to place many systems. Like $PROF, Synaptive was small and somewhat under-funded compared to the competition. To be clear, Synaptive made a certain mistake that $PROF has not made. Perhaps two. But still, Synaptive was loaded to the gills with talent. It had seemed just a few years ago that their future was bright.
0 · Reply
johntarlick
johntarlick Jun. 25 at 11:33 AM
not super new, but i only just caught it. the original founder of $PROF recently co-founded a boutique concierge prostate clinic to offer tulsaPRO in Texas. Interestingly, that clinic also offers HIFU. If the founder of $PROF thinks HIFU is still a viable choice, it nicely informs the comparative long term prospects for these two related technologies.
2 · Reply
dndodd
dndodd Jun. 22 at 1:27 PM
$PROF this company seems to be totally flying under the radar of many investors. At some point it will be seen for the game changer it is.
0 · Reply
QES
QES Jun. 12 at 12:42 AM
$PROF How PROF compares to $PRCT PROF is the clear winner
3 · Reply
BioTuesdays
BioTuesdays Jun. 10 at 5:24 PM
First BPH patient treated using Profound’s TULSA-PRO with TULSA-AI Volume Reduction $PROF https://biotuesdays.com/2025/06/10/first-bph-patient-treated-using-profounds-tulsa-pro-with-tulsa-ai-volume-reduction/
1 · Reply
QES
QES Jun. 10 at 5:04 PM
$PROF Naveen Kella, M.D., Founder of The Urology Place "He has performed nearly all of his robotic prostatectomy cases in the same hospital with the same team. " Is he switching to TULSA Pro? https://www.youtube.com/watch?v=H0iedrP-aLI&t=118s
0 · Reply
QES
QES Jun. 10 at 2:26 PM
$PROF Profound Medical Announces First Commercial BPH Patient Treatment Using TULSA-PRO® with TULSA-AI® Volume Reduction the first commercial benign prostatic hyperplasia (“BPH”) treatment utilizing the TULSA-PRO® system’s new TULSA-AI® Volume Reduction Module was successfully conducted yesterday by Naveen Kella, M.D., Founder of The Urology Place and an Adjunct Assistant Professor for the UT Health Science Center San Antonio. The TULSA procedure, performed using the TULSA-PRO® system, has the potential to become a mainstream treatment modality across the entire prostate disease spectrum; ranging from low-, intermediate-, or high-risk prostate cancer; to hybrid patients suffering from both prostate cancer and BPH; to men with BPH only; and also, to patients requiring salvage therapy for radio-recurrent localized prostate cancer. https://www.globenewswire.com/news-release/2025/06/10/3096565/33471/en/Profound-Medical-Announces-First-Commercial-BPH-Patient-Treatment-Using-TULSA-PRO-with-TULSA-AI-Volume-Reduction.html
0 · Reply
johntarlick
johntarlick Jun. 8 at 12:31 PM
Interesting, according to barchart some insiders bought into that recent dip $PROF, but not the one I'm really watching for.
0 · Reply
johntarlick
johntarlick Jun. 5 at 11:32 AM
$PROF Interesting podcast with CEO posted on the State of Medtech channel, deep dive on a lot of the topics that don't get much detail in the quarterly calls or press releases. But there's also more than a few canards to be aware of. For example, I was a Cedara shareholder back in the day, and what happened there was very different.
1 · Reply
BioTuesdays
BioTuesdays Jun. 4 at 2:48 PM
Profound Medical today announced that it has entered into a consulting agreement with Leonard Wheeler—former NFL player, entrepreneur, author, corporate consultant, co-executive director of the NFL Legends Community, and national podcaster $PROF https://biotuesdays.com/2025/06/04/leonard-wheeler-former-nfl-player-named-global-ambassador-for-profounds-tulsa-pro/
0 · Reply
Latest News on PROF
Profound Medical AUA 2025 Investor Event Agenda

Apr 15, 2025, 7:45 AM EDT - 2 months ago

Profound Medical AUA 2025 Investor Event Agenda


johntarlick
johntarlick Jul. 4 at 2:15 AM
another Canadian medtech with some parallels to $PROF (Synaptive) has just emerged from bankruptcy, with some new investment and an unknown future. Much like $PROF, they pioneered a new surgical tool with image-guidance. Like TulsaPro, the Synaptive exoscope was technically best in class. Like $PROF, Synaptive struggled to place many systems. Like $PROF, Synaptive was small and somewhat under-funded compared to the competition. To be clear, Synaptive made a certain mistake that $PROF has not made. Perhaps two. But still, Synaptive was loaded to the gills with talent. It had seemed just a few years ago that their future was bright.
0 · Reply
johntarlick
johntarlick Jun. 25 at 11:33 AM
not super new, but i only just caught it. the original founder of $PROF recently co-founded a boutique concierge prostate clinic to offer tulsaPRO in Texas. Interestingly, that clinic also offers HIFU. If the founder of $PROF thinks HIFU is still a viable choice, it nicely informs the comparative long term prospects for these two related technologies.
2 · Reply
dndodd
dndodd Jun. 22 at 1:27 PM
$PROF this company seems to be totally flying under the radar of many investors. At some point it will be seen for the game changer it is.
0 · Reply
QES
QES Jun. 12 at 12:42 AM
$PROF How PROF compares to $PRCT PROF is the clear winner
3 · Reply
BioTuesdays
BioTuesdays Jun. 10 at 5:24 PM
First BPH patient treated using Profound’s TULSA-PRO with TULSA-AI Volume Reduction $PROF https://biotuesdays.com/2025/06/10/first-bph-patient-treated-using-profounds-tulsa-pro-with-tulsa-ai-volume-reduction/
1 · Reply
QES
QES Jun. 10 at 5:04 PM
$PROF Naveen Kella, M.D., Founder of The Urology Place "He has performed nearly all of his robotic prostatectomy cases in the same hospital with the same team. " Is he switching to TULSA Pro? https://www.youtube.com/watch?v=H0iedrP-aLI&t=118s
0 · Reply
QES
QES Jun. 10 at 2:26 PM
$PROF Profound Medical Announces First Commercial BPH Patient Treatment Using TULSA-PRO® with TULSA-AI® Volume Reduction the first commercial benign prostatic hyperplasia (“BPH”) treatment utilizing the TULSA-PRO® system’s new TULSA-AI® Volume Reduction Module was successfully conducted yesterday by Naveen Kella, M.D., Founder of The Urology Place and an Adjunct Assistant Professor for the UT Health Science Center San Antonio. The TULSA procedure, performed using the TULSA-PRO® system, has the potential to become a mainstream treatment modality across the entire prostate disease spectrum; ranging from low-, intermediate-, or high-risk prostate cancer; to hybrid patients suffering from both prostate cancer and BPH; to men with BPH only; and also, to patients requiring salvage therapy for radio-recurrent localized prostate cancer. https://www.globenewswire.com/news-release/2025/06/10/3096565/33471/en/Profound-Medical-Announces-First-Commercial-BPH-Patient-Treatment-Using-TULSA-PRO-with-TULSA-AI-Volume-Reduction.html
0 · Reply
johntarlick
johntarlick Jun. 8 at 12:31 PM
Interesting, according to barchart some insiders bought into that recent dip $PROF, but not the one I'm really watching for.
0 · Reply
johntarlick
johntarlick Jun. 5 at 11:32 AM
$PROF Interesting podcast with CEO posted on the State of Medtech channel, deep dive on a lot of the topics that don't get much detail in the quarterly calls or press releases. But there's also more than a few canards to be aware of. For example, I was a Cedara shareholder back in the day, and what happened there was very different.
1 · Reply
BioTuesdays
BioTuesdays Jun. 4 at 2:48 PM
Profound Medical today announced that it has entered into a consulting agreement with Leonard Wheeler—former NFL player, entrepreneur, author, corporate consultant, co-executive director of the NFL Legends Community, and national podcaster $PROF https://biotuesdays.com/2025/06/04/leonard-wheeler-former-nfl-player-named-global-ambassador-for-profounds-tulsa-pro/
0 · Reply
QES
QES Jun. 4 at 2:31 PM
$PROF Notice that the hiring of Laurie Vertuccio as the new Vice President of Global Marketing coincides with Profound's newly announced consulting agreement with Leonard Wheeler. “To that end, we are excited to partner with Leonard and look forward to working with him to soon launch an immersive TULSA-PRO® awareness campaign on multiple fronts, including digital media, social media, podcasting, and more.” IMO, the biggest issue for PROF is that essentially nobody knows about TULSA Pro. Looks like that should change rapidly.
0 · Reply
QES
QES May. 27 at 8:05 PM
$PROF @Tdenton16 https://www.youtube.com/watch?v=icJ64_IgXFs Don's story
0 · Reply
QES
QES May. 27 at 7:25 PM
$PROF Laurie Vertuccio has joined Profound Medical (NASDAQ:PROF; TSX:PRN) as Vice President of Global Marketing. https://www.linkedin.com/posts/vertuccio_newbeginnings-prostatecancerawareness-medicalinnovation-activity-7333188858211192833-EjSt
0 · Reply
BioTuesdays
BioTuesdays May. 27 at 7:17 PM
Accomplished medtech industry veteran, Laurie Vertuccio, has joined Profound Medical as Vice President of Global Marketing $PROF https://biotuesdays.com/2025/05/27/accomplished-medtech-industry-veteran-laurie-vertuccio-joins-profound-medical-as-vp-of-global-marketing/
0 · Reply
QES
QES May. 27 at 2:33 PM
$PROF @Tdenton16 https://biotuesdays.com/2024/01/12/satisfied-tulsa-prostate-cancer-procedure-patient-discloses-5-2-stake-in-profound-medical/
0 · Reply
QES
QES May. 27 at 2:31 PM
$PROF @Tdenton16 https://en.wikipedia.org/wiki/Don_Daseke
0 · Reply
QES
QES May. 22 at 6:21 PM
$PROF KIMS Hospitals 1 week ago Experience the future of prostate treatment with the TULSA-PRO System at KIMS Hospitals – the only hospital in India and first in South Asia to offer this breakthrough, incision-less solution for Prostate Cancer & BPH. ✅ No Scars or Surgical Cuts ✅ Radiation-Free ✅ Faster Recovery ✅ FDA Approved ✅ Safer for Sexual & Bladder Health 💡 A game-changer in prostate care – precision meets comfort.
1 · Reply
QES
QES May. 22 at 1:51 AM
$PROF India now has Tulsa Pro.
0 · Reply
QES
QES May. 20 at 10:01 PM
$PROF The Evolution of Prostate Surgery: What Has Changed? | Presented by: Y Mark Hong, MD https://www.youtube.com/watch?v=xphVmiMiY9g
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures May. 20 at 8:00 PM
$PROF CEO purchased 22,030 shares at $4.55 for a total of $100,151. Menawat Arun Swarup now owns 587,089 shares. https://ceo-buys.com
1 · Reply
QES
QES May. 19 at 5:52 PM
$PROF https://finance.yahoo.com/news/arun-menawat-bought-2-1-122026881.html
0 · Reply